Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kate Skolnik

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
F1000Research|June 5, 2018
Recent advances in the understanding and management of cystic fibrosis pulmonary exacerbationsKate Skolnik, Bradley S Quon
Respirology (Carlton, Vic.)|June 11, 2015
Unclassifiable interstitial lung disease: A reviewKate Skolnik, Christopher J Ryerson
Clinics in Chest Medicine|August 12, 2017
Cryptococcal Lung InfectionsKate Skolnik, Shaunna Huston, Christopher H Mody
Current Treatment Options in Infectious Diseases|December 31, 2016
Nontuberculous Mycobacteria in Cystic FibrosisKate Skolnik, Gordon Kirkpatrick, Bradley S Quon
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|October 15, 2019
Respiratory Complications Associated With Acetazolamide Use in the Management of Idiopathic Intracranial HypertensionFiona Costello, Kate Skolnik, Justyna Sarna, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 19, 2016
Coronary artery disease in cystic fibrosis: An emerging concern?Kate Skolnik, Robert D Levy, Pearce G Wilcox, et al.
Respiratory Research|March 2, 2016
Birt-Hogg-Dubé syndrome: a large single family cohortKate Skolnik, Willis H Tsai, Kimberly Dornan, et al.
Plos One|February 9, 2017
Clinical utility of C-reactive protein to predict treatment response during cystic fibrosis pulmonary exacerbationsAshutosh Sharma, Gordon Kirkpatrick, Virginia Chen, et al.
Scientific Reports|May 12, 2019
A Systematic Review of the Clinical Efficacy and Safety of CFTR Modulators in Cystic FibrosisAl-Rahim R Habib, Majid Kajbafzadeh, Sameer Desai, et al.
BMC Infectious Diseases|October 4, 2017
Group B streptococcus (GBS) is an important pathogen in human disease- but what about in cystic fibrosis?Kate Skolnik, Austin Nguyen, Christina S Thornton, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
F1000Research|June 5, 2018
Recent advances in the understanding and management of cystic fibrosis pulmonary exacerbationsKate Skolnik, Bradley S Quon
Respirology (Carlton, Vic.)|June 11, 2015
Unclassifiable interstitial lung disease: A reviewKate Skolnik, Christopher J Ryerson
Clinics in Chest Medicine|August 12, 2017
Cryptococcal Lung InfectionsKate Skolnik, Shaunna Huston, Christopher H Mody
Current Treatment Options in Infectious Diseases|December 31, 2016
Nontuberculous Mycobacteria in Cystic FibrosisKate Skolnik, Gordon Kirkpatrick, Bradley S Quon
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|October 15, 2019
Respiratory Complications Associated With Acetazolamide Use in the Management of Idiopathic Intracranial HypertensionFiona Costello, Kate Skolnik, Justyna Sarna, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 19, 2016
Coronary artery disease in cystic fibrosis: An emerging concern?Kate Skolnik, Robert D Levy, Pearce G Wilcox, et al.
Respiratory Research|March 2, 2016
Birt-Hogg-Dubé syndrome: a large single family cohortKate Skolnik, Willis H Tsai, Kimberly Dornan, et al.
Plos One|February 9, 2017
Clinical utility of C-reactive protein to predict treatment response during cystic fibrosis pulmonary exacerbationsAshutosh Sharma, Gordon Kirkpatrick, Virginia Chen, et al.
Scientific Reports|May 12, 2019
A Systematic Review of the Clinical Efficacy and Safety of CFTR Modulators in Cystic FibrosisAl-Rahim R Habib, Majid Kajbafzadeh, Sameer Desai, et al.
BMC Infectious Diseases|October 4, 2017
Group B streptococcus (GBS) is an important pathogen in human disease- but what about in cystic fibrosis?Kate Skolnik, Austin Nguyen, Christina S Thornton, et al.
Pageof 2